This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.93% per year. These returns cover a period from January 1, 1988 through October 6, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
medical: Archive
Ensign Group Expands Foothold in Three U.S. States With Facility Buyouts
by Zacks Equity Research
ENSG adds four skilled nursing facilities across Colorado, Arizona and Kansas, pushing its total healthcare operations to 373 nationwide.
ISRGPositive Net Change ANIPPositive Net Change ENSGNegative Net Change COLLPositive Net Change
medical
TLRY Stock Loses 38% in a Month: Should You Buy the Dip?
by Sundeep Ganoria
Tilray's slump deepens as a tighter U.S. hemp rule and a reverse split stir uncertainty despite gains in global cannabis sales.
CGCPositive Net Change TLRYNegative Net Change CURLFPositive Net Change
marijuana medical
Cooper Companies to Post Q4 Earnings: What's in Store for the Stock?
by Zacks Equity Research
COO is set to post Q4 earnings as MyDAY momentum offsets Clariti and APAC softness, with revenues and earnings expected to rise.
EWNegative Net Change HOLXPositive Net Change DXCMPositive Net Change COOPositive Net Change
medical medical-devices
TMO Stock Benefits From New Bioprocess Design Center in Asia
by Zacks Equity Research
Thermo Fisher expands its Bioprocess Design Centers across Asia, boosting biomanufacturing speed, efficiency and regional innovation.
BSXNegative Net Change MDTNegative Net Change TMOPositive Net Change GMEDNegative Net Change
medical
Bayer Stock Up as Government Backs Supreme Court Review in Roundup Case
by Zacks Equity Research
Bayer shares jump after the U.S. Solicitor General backs a Supreme Court review of its Roundup case, adding momentum to its strong 2025 run.
JNJNegative Net Change BAYRYPositive Net Change ANIPPositive Net Change CRMDPositive Net Change
biotechnology biotechs medical pharmaceuticals
EHC Opens New Lake Worth Rehab Hospital to Meet Rising Demand
by Zacks Equity Research
Encompass Health expands its Florida presence with a new Lake Worth rehab hospital, adding 50 beds and advanced therapy services to meet rising demand.
UHSNegative Net Change VCYTPositive Net Change EHCNegative Net Change BTSGNegative Net Change
medical smart-health
Hims & Hers Expands Care Scope as Prescription Platforms Evolve
by Debanjana Dey
HIMS grows its telehealth-to-prescription model with new offerings in weight loss, hormone care and diagnostics.
AMWLPositive Net Change HIMSPositive Net Change LFMDPositive Net Change
medical medical-devices
PCRX's Iovera Outperforms RFA Therapy in Pilot Study for Low Back Pain
by Zacks Equity Research
Pacira BioSciences' iovera shows stronger, longer-lasting relief than RFA in a pilot CLBP study, highlighting its tissue-sparing approach and potential spine-care impact.
PCRXPositive Net Change CRMDPositive Net Change ADMAPositive Net Change ARQTPositive Net Change
biotechnology biotechs medical pharmaceuticals
Zacks Industry Outlook Highlights Aflac, Unum Group, Globe Life and Trupanion
by Zacks Equity Research
Aflac, Unum, Globe Life and Trupanion stand out as insurers navigating pricing pressure and rising medical costs with disciplined underwriting and tech-driven efficiency.
AFLPositive Net Change UNMNegative Net Change TRUPPositive Net Change GLNegative Net Change
insurance medical
Zacks.com featured highlights include Agnico Eagle Mines, General Motors, Great Lakes Dredge & Dock, BrightSpring Health Services and Everus Construction
by Zacks Equity Research
GM, AEM, GLDD, BTSG and ECG stand out as market leaders, showcasing strong relative price strength amid a resilient U.S. economy.
GMPositive Net Change AEMNegative Net Change GLDDPositive Net Change BTSGNegative Net Change ECGPositive Net Change
auto-tires-trucks construction gold medical
Can LLY Strengthen Its Lead as GLP-1 Price Cuts Reshape the Market?
by Ahan Chakraborty
Eli Lilly cuts Zepbound prices, igniting a fierce battle with Novo Nordisk to expand access and defend share in the obesity market.
NVOPositive Net Change LLYNegative Net Change AMGNPositive Net Change VKTXPositive Net Change
biotechnology biotechs medical pharmaceuticals
Acadia Healthcare Cuts 2025 Outlook After Liability Bomb Went Off
by Kaibalya Pravo Dey
ACHC cuts its 2025 outlook as liability costs soar, with surging claims and weaker reinsurance sharply hitting earnings and EBITDA.
THCNegative Net Change HCANegative Net Change ACHCNegative Net Change
medical
Vertiv and Molina Healthcare have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
VRT surges on AI-driven demand while MOH struggles with declining Medicaid enrollment and mounting costs.
GSPositive Net Change MOHPositive Net Change FULTPositive Net Change VRTNegative Net Change BLFYPositive Net Change
computers finance medical
Should You Continue to Hold RMD Stock in Your Portfolio?
by Zacks Equity Research
Resmed sees strong mask sales, strategic acquisitions and international expansion despite macro and competitive challenges.
BSXNegative Net Change MDTNegative Net Change RMDPositive Net Change GMEDNegative Net Change
medical medical-devices
The US Rollout of MiniMed 780G With Abbott's Sensor May Lift MDT Stock
by Zacks Equity Research
Medtronic begins the U.S. rollout of MiniMed 780G with Abbott's Instinct sensor, advancing diabetes care.
ABTNegative Net Change BSXNegative Net Change MDTNegative Net Change GMEDNegative Net Change
medical medical-devices
KMT, UHS, and More Are Now Strong Buy Stocks (Dec. 3)
by Zacks Equity Research
KMT, UHS, WT, OII and MAX have been added to the Zacks Rank #1 (Strong Buy) List on Dec.3, 2025.
UHSNegative Net Change OIIPositive Net Change KMTPositive Net Change MAXPositive Net Change WTPositive Net Change
finance industrial-products medical
Bear of the Day: Molina Healthcare (MOH)
by Bryan Hayes
The company faces escalating operational and financial pressures that threaten its outlook.
MOHPositive Net Change
earnings hmo insurance investing medical
Best Growth Stocks to Buy for Dec.3
by Zacks Equity Research
MU, GLDD and UHS made it to the Zacks Rank #1 (Strong Buy) growth stocks list on Dec. 3, 2025
UHSNegative Net Change MUNegative Net Change GLDDPositive Net Change
medical
Best Value Stocks to Buy for Dec. 3
by Zacks Equity Research
UHS, OII and WT made it to the Zacks Rank #1 (Strong Buy) value stocks list on Dec. 3, 2025
UHSNegative Net Change OIIPositive Net Change WTPositive Net Change
medical
REGN & Tessera Collaborate to Develop Gene-Editing Therapy for AATD
by Zacks Equity Research
Regeneron teams up with Tessera to advance TSRA-196, aiming to correct the genetic cause of AATD as preclinical data support its move toward trials.
REGNNegative Net Change RHHBYPositive Net Change ANIPPositive Net Change CRMDPositive Net Change
biotechnology biotechs medical pharmaceuticals
BHC Stock Up as Solta Acquires Shibo's Aesthetics Distribution Business
by Zacks Equity Research
BHC jumps 11% as Solta Medical acquires Wuhan Shibo Zhenmei, gaining full control of its China aesthetics distribution business.
FOLDPositive Net Change ANIPPositive Net Change CRMDPositive Net Change BHCPositive Net Change
biotechnology biotechs medical pharmaceuticals
Here's Why You Should Retain Ecolab Stock in Your Portfolio Now
by Zacks Equity Research
ECL's robust product lineup, innovation-driven growth and strong Q2 results underscore its long-term potential despite macroeconomic headwinds.
BSXNegative Net Change ECLNegative Net Change ISRGPositive Net Change MEDPNegative Net Change
medical medical-devices
GEHC Unveils Allia Moveo to Elevate Mobility in Interventional Care
by Zacks Equity Research
GE HealthCare launches Allia Moveo with a cable-free C-arm and AI tools, aiming to elevate mobility, access and workflow in interventional care.
BSXNegative Net Change ISRGPositive Net Change MEDPNegative Net Change GEHCPositive Net Change
medical medical-devices
LLY Lowers Prices of Zepbound Vials for Cash Buyers on DTC Website
by Zacks Equity Research
Eli Lilly trims Zepbound vial prices on LillyDirect, offering lower monthly costs for self-paying patients across multiple doses.
PFEPositive Net Change NVOPositive Net Change LLYNegative Net Change VKTXPositive Net Change
biotechs medical pharmaceuticals
GM and 4 Stocks With Relative Price Strength to Buy Now
by Nilanjan Choudhury
AEM, GM, GLDD, BTSG and ECG stand out with strong relative price strength and rising estimates as market momentum stays supportive.
GMPositive Net Change AEMNegative Net Change GLDDPositive Net Change BTSGNegative Net Change ECGPositive Net Change
auto-tires-trucks basic-materials construction medical